Particle.news

Download on the App Store

NHS PROGRESS Study Embeds Pharmacogenomics in Primary Care, Alters Treatment for 25% of Patients

Interim analysis shows tailored prescribing guidance delivered within seven days, setting the stage for health economic evaluations.

Image

Overview

  • The programme recruited patients across 20 NHS sites and integrated pharmacogenomic data into electronic health records in both GP practices and hospitals.
  • Genetic testing identified actionable variants affecting common medications in 95% of the first 500 participants.
  • Clinicians adjusted prescriptions to safer or more effective therapies for over one in four patients based on genomic guidance.
  • The informatics solution is compatible with multiple genetic testing platforms and major EHR systems, enabling seamless clinical workflow integration.
  • Researchers will next assess how pharmacogenomic-informed prescribing influences follow-up appointments, emergency visits and overall medication costs.